EP Patent

EP1065200A1 — Aminoisoquinoline derivatives

Assigned to Ajinomoto Co Inc · Expires 2001-01-03 · 25y expired

What this patent protects

Aminoisoquinoline derivatives represented by formulae (I and II), analogs thereof or pharmaceutically acceptable salts of the same. Because of having excellent inhibitory effects on activated blood coagulation factor X, these compounds are useful as active ingredients in anticoag…

USPTO Abstract

Aminoisoquinoline derivatives represented by formulae (I and II), analogs thereof or pharmaceutically acceptable salts of the same. Because of having excellent inhibitory effects on activated blood coagulation factor X, these compounds are useful as active ingredients in anticoagulants or preventives/remedies for thrombosis or embolism.

Drugs covered by this patent

Patent Metadata

Patent number
EP1065200A1
Jurisdiction
EP
Classification
—
Expires
2001-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Ajinomoto Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.